Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Hester

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
American Journal of Epidemiology|February 6, 2026
Quantitative bias analyses to address measurement error in time-to-event endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
JCO Oncology Practice|December 20, 2024
Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing AdministrationTyler B Sandahl, Scott A Soefje, Rafael Fonseca, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
American Journal of Epidemiology|February 6, 2026
Quantitative bias analyses to address measurement error in time-to-event endpointsBenjamin Ackerman, Ryan W Gan, Youyi Zhang, et al.
JCO Oncology Practice|December 20, 2024
Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing AdministrationTyler B Sandahl, Scott A Soefje, Rafael Fonseca, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Pageof 2